First Trust Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,218
Closed -$913K 2481
2020
Q3
$913K Sell
8,218
-409
-5% -$43.9K ﹤0.01% 1805
2020
Q2
$882K Sell
8,627
-757
-8% -$81K ﹤0.01% 1796
2020
Q1
$1.01M Buy
9,384
+3,168
+51% +$364K ﹤0.01% 1616
2019
Q4
$723K Sell
6,216
-783
-11% -$90.7K ﹤0.01% 2002
2019
Q3
$801K Sell
6,999
-649
-8% -$64.5K ﹤0.01% 1954
2019
Q2
$729K Sell
7,648
-1,530
-17% -$144K ﹤0.01% 1981
2019
Q1
$837K Sell
9,178
-3,053
-25% -$250K ﹤0.01% 1932
2018
Q4
$928K Sell
12,231
-17,252
-59% -$1.27M ﹤0.01% 1861
2018
Q3
$2.36M Sell
29,483
-2,861
-9% -$267K ﹤0.01% 1571
2018
Q2
$3.21M Buy
+32,344
New +$2.79M 0.01% 1349
2018
Q1
Sell
-30,251
Closed -$2.38M 2475
2017
Q4
$2.38M Buy
30,251
+11,437
+61% +$951K 0.01% 1418
2017
Q3
$1.74M Buy
18,814
+2,641
+16% +$254K ﹤0.01% 1563
2017
Q2
$1.83M Buy
16,173
+4,612
+40% +$515K ﹤0.01% 1539
2017
Q1
$1.16M Buy
11,561
+3,053
+36% +$326K ﹤0.01% 1802
2016
Q4
$915K Sell
8,508
-167
-2% -$19.5K ﹤0.01% 1873
2016
Q3
$1.08M Sell
8,675
-1,253
-13% -$148K ﹤0.01% 1669
2016
Q2
$1.06M Sell
9,928
-162
-2% -$18.8K ﹤0.01% 1673
2016
Q1
$1.16M Sell
10,090
-2,132
-17% -$250K ﹤0.01% 1609
2015
Q4
$1.74M Sell
12,222
-4,789
-28% -$553K ﹤0.01% 1466
2015
Q3
$1.53M Sell
17,011
-4,976
-23% -$525K ﹤0.01% 1534
2015
Q2
$2.53M Buy
+21,987
New +$2.31M 0.01% 1388

Other funds holding CBPO

First Trust Advisors's CBPO Position: Q4 2020 in Review

First Trust Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 8,218 shares — an estimated $913K sold.

First Trust Advisors first reported a position in CBPO in Q2 2015 and held it in 21 quarters. The position peaked at $3.21M in Q2 2018. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

  • First Trust Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
  • First Trust Advisors sold 8,218 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $913K.
  • First Trust Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 21 quarters.
  • First Trust Advisors's China Biologic Products Holdings, Inc. position peaked at $3.21M in Q2 2018.
  • 89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on First Trust Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.